Israel - heprea - Ministry of Health

גאמידה בע"מ - מומחה - היצרות בכלי דם

Israel - heprea - Ministry of Health

j-c healthcare ltd. - רופא - צינתורי ראש

Israel - heprea - Ministry of Health

j-c healthcare ltd. - רופא - צינתורי ראש

Israel - heprea - Ministry of Health

emedix ltd. - רופא - קנולות וציוד לניתוחי חזה + רטרקטורים

Israel - heprea - Ministry of Health

י.גיל מדיקל בע"מ - מומחה - קנולות עורקיות וורידיות לניתוחי לב חזה

Israel - heprea - Ministry of Health

inspire md ltd - רופא - mguard prime coronary stent system is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • treatment of coronary lesion in patients undergoing primary or rescue pci for acute st-segment elevation myocardial infarction(stemi) • treatment of coronary lesion having atherothrombotic appearance in patients with non st-elevation acute coronary syndromes (unstable angina and non st-segment elevation myocardial infarction).

Israel - heprea - Ministry of Health

novartis israel ltd - onasemnogene abeparvovec - תרחיף - onasemnogene abeparvovec 2 x 10^13 vg / 1 ml - onasemnogene abeparvovec

Israel - heprea - Ministry of Health

medici medical ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.5 g / 10 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- wiskott aldrich syndromemyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.children with congenital aids and recurrent infections.immunomodulation :idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.guillain barr? syndrome.kawasaki disease.allogeneic bone marrow transplantation

Israel - heprea - Ministry of Health

omrix biopharmaceuticals - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 50 mg/ml mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy * primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinemia or hypogammaglobulinemia) * myeloma or chronic lymphocytic leukemia (cll) with severe secondary hypogammaglobulinemia and recurrent infections. * children with congenital aids and recurrent infections - immunomodulation * idiopathic thrombocytopenic purpura (itp) * guillain barre syndrome * kawasaki disease - allogenic bone marrow transplantation

Israel - heprea - Ministry of Health

padagis israel agencies ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.1 g/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - gamunex is indicated as replacement therapy of primary immunodeficiency (pi) states in which severe impaiment of antibody forming capacity has been shown, such as congential agammaglobulinemia, common variable immunodeficiency, x-limked immunodeficiency with hyper igm, wiskott- aldrich syndrom, and severed combined immunodeficiencies. gamunex is also indicated in idiopathic thrombocytopenia purpura (itp) to raise platelet counts to prevent bleeding or to allow a patient with itp to undergo surgery.treatment of chronic inflammatory demyelinating polyneuropathy (cidp).